Kristen Ambrose, SVP & Chief Accounting Officer at VERTEX PHARMACEUTICALS INC / MA (VRTX), sold 578 shares at $329.82 ($191K) on 2023-05-30, disclosed to the SEC on 2023-06-01.
Scheduled sale ($191k) by SVP & Chief Accounting Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $329.82 | 289 | $95K | 50.0% |
| 2 | $329.82 | 289 | $95K | 50.0% |
| Total | $329.82 avg | 578 | $191K | 100% |
| Filing → |
| VRTX | SELL | 2026-02-19 | $1.1M | — | Filing → |
| VRTX | SELL | 2026-02-12 | $634K | — | Filing → |
| VRTX | SELL | 2025-02-26 | $850K | — | Filing → |